Tag: nemaura medical
May 29, 2019
Nemaura Notches CE Mark for SugarBEAT
With the CE Mark approval, Nemaura Medical will be able to sell its SugarBEAT device across the European Union. May 29, 2019
Nemaura Receives CE Mark Approval of SugarBEAT
Nemaura Medical (NASDAQ:NMRD) has announced it has received CE Mark approval for SugarBEAT, a non-invasive device for diabetics and pre-diabetics.... February 12, 2019
Nemaura Reports Third Quarter 2018 Financial Results
Nemaura Medical (NASDAQ:NMRD) has announced its financial results for Q3 ended December 30, 2018. As quoted in the press release:... December 18, 2018
Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial
Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for... December 18, 2018
Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering
Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for...
December 6, 2018
Medical Device Trends 2018: M&A, Tech and Regulatory Impact
With 2018 coming to a close, here the Investing News Network takes a look at the biggest medical device trends... November 20, 2018